E
NeuroMetrix, Inc.
NURO
$4.41
$0.08591.99%
E
Sell
3/20/2025Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 3/20/2025 due to a decline in the volatility index.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 3/20/2025 due to a decline in the volatility index.
D
Sell
3/5/2025Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 3/5/2025 due to an increase in the total return index and volatility index.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 3/5/2025 due to an increase in the total return index and volatility index.
E
Sell
2/11/2025Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 2/11/2025 due to a decline in the volatility index.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 2/11/2025 due to a decline in the volatility index.
D
Sell
1/27/2025Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 1/27/2025 due to an increase in the total return index and volatility index.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 1/27/2025 due to an increase in the total return index and volatility index.
E
Sell
1/7/2025Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 1/7/2025 due to a decline in the volatility index and total return index.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 1/7/2025 due to a decline in the volatility index and total return index.
D
Sell
12/20/2024Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 12/20/2024 due to an increase in the growth index and volatility index. EBIT increased 4.74% from -$1.83M to -$1.74M.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 12/20/2024 due to an increase in the growth index and volatility index. EBIT increased 4.74% from -$1.83M to -$1.74M.
E
Sell
11/9/2023Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 11/9/2023 due to a decline in the volatility index, growth index and solvency index. Operating cash flow declined 42.09% from -$1.45M to -$2.06M, total revenue declined 27.33% from $1.66M to $1.2M, and EBIT declined 20.78% from -$1.62M to -$1.96M.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 11/9/2023 due to a decline in the volatility index, growth index and solvency index. Operating cash flow declined 42.09% from -$1.45M to -$2.06M, total revenue declined 27.33% from $1.66M to $1.2M, and EBIT declined 20.78% from -$1.62M to -$1.96M.
D
Sell
7/21/2023Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 7/21/2023 due to an increase in the volatility index, growth index and solvency index. Operating cash flow increased 24.38% from -$1.48M to -$1.12M.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 7/21/2023 due to an increase in the volatility index, growth index and solvency index. Operating cash flow increased 24.38% from -$1.48M to -$1.12M.
E
Sell
3/14/2023Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 03/14/2023.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 2/8/2023 due to a large decline in the total return index.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 2/8/2023 due to a large decline in the total return index.
D
Sell
12/22/2022Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 12/22/2022 due to a major decline in the growth index, total return index and volatility index. Operating cash flow declined 165.74% from -$838.3 to -$2.23M, EBIT declined 41.54% from -$1.21M to -$1.71M, and earnings per share declined from -$0.1655 to -$0.2286.
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 12/22/2022 due to a major decline in the growth index, total return index and volatility index. Operating cash flow declined 165.74% from -$838.3 to -$2.23M, EBIT declined 41.54% from -$1.21M to -$1.71M, and earnings per share declined from -$0.1655 to -$0.2286.
D
Sell
5/31/2022Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 5/31/2022 due to an increase in the total return index and volatility index.
D
Sell
5/13/2022Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 5/13/2022 due to a large decline in the solvency index. The quick ratio declined from 16.76 to 14.16.
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 5/13/2022 due to a large decline in the solvency index. The quick ratio declined from 16.76 to 14.16.
D
Sell
5/5/2022Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 5/5/2022 due to an increase in the total return index and valuation index.
D
Sell
4/20/2022Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 4/20/2022 due to a decline in the growth index, volatility index and solvency index. EBIT declined 46% from -$688 to -$1M, earnings per share declined from -$0.1181 to -$0.15, and total revenue declined 11.83% from $2.06M to $1.82M.
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 4/20/2022 due to a decline in the growth index, volatility index and solvency index. EBIT declined 46% from -$688 to -$1M, earnings per share declined from -$0.1181 to -$0.15, and total revenue declined 11.83% from $2.06M to $1.82M.
D
Sell
11/23/2021Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 11/23/2021 due to an increase in the valuation index.
D
Sell
11/8/2021Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
NeuroMetrix, Inc. (NURO) was downgraded to D- from D on 11/8/2021 due to a decline in the valuation index.
D
Sell
7/24/2020Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 7/24/2020 due to a large increase in the growth index, solvency index and total return index. The quick ratio increased from 1.17 to 2.49, debt to equity declined from 0.24 to 0.11, and earnings per share increased from -$0.4511 to -$0.2826.
NeuroMetrix, Inc. (NURO) was upgraded to D from D- on 7/24/2020 due to a large increase in the growth index, solvency index and total return index. The quick ratio increased from 1.17 to 2.49, debt to equity declined from 0.24 to 0.11, and earnings per share increased from -$0.4511 to -$0.2826.
D
Sell
4/14/2020Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 4/14/2020 due to an increase in the volatility index, efficiency index and valuation index. Net income increased 24.77% from -$1.4M to -$1.06M.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 4/14/2020 due to an increase in the volatility index, efficiency index and valuation index. Net income increased 24.77% from -$1.4M to -$1.06M.
E
Sell
7/19/2019Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D on 7/19/2019 due to a significant decline in the efficiency index, growth index and solvency index. Operating cash flow declined 633.44% from $420.4 to -$2.24M, earnings per share declined from $0.15 to -$0.3716, and net income declined 263.97% from $2.05M to -$3.36M.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D on 7/19/2019 due to a significant decline in the efficiency index, growth index and solvency index. Operating cash flow declined 633.44% from $420.4 to -$2.24M, earnings per share declined from $0.15 to -$0.3716, and net income declined 263.97% from $2.05M to -$3.36M.
D
Sell
10/19/2018Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D from E+ on 10/19/2018 due to a significant increase in the efficiency index, solvency index and volatility index. Net income increased 89.25% from $573.9 to $1.09M, total capital increased 14.74% from $7.72M to $8.86M, and the quick ratio increased from 2.01 to 2.19.
NeuroMetrix, Inc. (NURO) was upgraded to D from E+ on 10/19/2018 due to a significant increase in the efficiency index, solvency index and volatility index. Net income increased 89.25% from $573.9 to $1.09M, total capital increased 14.74% from $7.72M to $8.86M, and the quick ratio increased from 2.01 to 2.19.
E
Sell
4/20/2018Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 4/20/2018 due to a decline in the efficiency index, solvency index and growth index. EBIT declined 24.86% from -$2.88M to -$3.6M.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 4/20/2018 due to a decline in the efficiency index, solvency index and growth index. EBIT declined 24.86% from -$2.88M to -$3.6M.
D
Sell
2/12/2018Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 2/12/2018 due to a large increase in the growth index and efficiency index. Earnings per share increased from -$3.1148 to -$1.173, total revenue increased 38.99% from $3.55M to $4.93M, and net income increased 17.92% from -$3.51M to -$2.88M.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 2/12/2018 due to a large increase in the growth index and efficiency index. Earnings per share increased from -$3.1148 to -$1.173, total revenue increased 38.99% from $3.55M to $4.93M, and net income increased 17.92% from -$3.51M to -$2.88M.
E
Sell
4/21/2017Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 4/21/2017 due to a decline in the growth index, efficiency index and total return index. Earnings per share declined from -$0.52 to -$0.9084, EBIT declined 15.72% from -$2.86M to -$3.31M, and net income declined 14.86% from -$2.81M to -$3.23M.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 4/21/2017 due to a decline in the growth index, efficiency index and total return index. Earnings per share declined from -$0.52 to -$0.9084, EBIT declined 15.72% from -$2.86M to -$3.31M, and net income declined 14.86% from -$2.81M to -$3.23M.
D
Sell
2/13/2017Upgraded
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 2/13/2017 due to an increase in the growth index and efficiency index. Earnings per share increased from -$0.7639 to -$0.52, net income increased 27.99% from -$3.91M to -$2.81M, and EBIT increased 27.86% from -$3.97M to -$2.86M.
NeuroMetrix, Inc. (NURO) was upgraded to D- from E+ on 2/13/2017 due to an increase in the growth index and efficiency index. Earnings per share increased from -$0.7639 to -$0.52, net income increased 27.99% from -$3.91M to -$2.81M, and EBIT increased 27.86% from -$3.97M to -$2.86M.
E
Sell
11/18/2016Downgrade
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 11/18/2016 due to a decline in the solvency index, volatility index and efficiency index. The quick ratio declined from 4.01 to 2.27, and total capital declined 33.33% from $11.56M to $7.71M.
NeuroMetrix, Inc. (NURO) was downgraded to E+ from D- on 11/18/2016 due to a decline in the solvency index, volatility index and efficiency index. The quick ratio declined from 4.01 to 2.27, and total capital declined 33.33% from $11.56M to $7.71M.
D
Sell
3/11/2016Downgrade
NeuroMetrix Inc. (NURO) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, efficiency index and total return index.
NeuroMetrix Inc. (NURO) was downgraded to D- from D on 3/11/2016 due to a substantial decline in the volatility index, efficiency index and total return index.
NASDAQ
04/10/2025 12:27PM Eastern
Quotes delayed
